{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:49:02Z","timestamp":1780616942196,"version":"3.54.1"},"reference-count":42,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T00:00:00Z","timestamp":1235347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>During the development of atherosclerotic plaques, vascular smooth muscle cells (VSMCs) migrate from the media to the intima through the basement membrane and interstitial collagenous matrix, and proliferate to form neointima. Here, we investigate the mechanism of VSMC migration and proliferation caused by aggretin, a snake venom integrin \u03b12\u03b21 agonist.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>Cultures of rat and human VSMCs were treated with aggretin and the signal transduction pathways induced by this agonist were examined by Western blotting, immunoprecipitation and electrophoretic mobility shift assay techniques.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>Aggretin\u2010induced VSMC proliferation was blocked by a monoclonal antibody (mAb) against integrin \u03b12 (AII2E10) or against the platelet\u2010derived growth factor receptor (PDGFR)\u2010\u03b2. Proliferation was also blocked by inhibition of the tyrosine kinase Src with PP2, phospholipase C (PLC) with U73122, extracellular signal\u2010regulated kinase (ERK) with PD98059 or nuclear factor\u2010kappa B (NF\u2010kB) activation with pyrrolidine dithiocarbamate (PDTC). VSMC migration towards immobilized aggretin was increased in a modified Boyden chamber and this effect was blocked by \u03b12\u03b21\u2010Src\u2010PLC\u2010MAPK axis inhibitors, but not by PDTC, PDGFR\u2010\u03b2 mAb, or a phosphoinositide\u20103 kinase inhibitor, LY294002. Aggretin stimulated the phosphorylation of PDGFR\u2010\u03b2, Src and ERK in a time\u2010dependent manner. NF\u2010kB translocation and platelet\u2010derived growth factor (PDGF)\u2010BB production were also observed. The ERK activation, NF\u2010kB translocation and PDGF\u2010BB production were blocked by PP2, U73122 and PD98059.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>Aggretin induces VSMC proliferation and migration mainly through binding to integrin \u03b12\u03b21, and subsequently activates Src, PLC and ERK pathways, inducing NF\u2010kB activation and PDGF production.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2008.00095.x","type":"journal-article","created":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T08:19:26Z","timestamp":1235377166000},"page":"846-856","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The integrin \u03b1<sub>2<\/sub>\u03b2<sub>1<\/sub>agonist, aggretin, promotes proliferation and migration of VSMC through NF\u2010kB translocation and PDGF production"],"prefix":"10.1111","volume":"156","author":[{"given":"Ching\u2010Hu","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan\u2010Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien\u2010Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui\u2010Chin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tur\u2010Fu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,26]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707746"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119849"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.24.14066"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.151.7.1549"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb26691.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1016-8478(23)13137-2","article-title":"The Src\/PLC\/PKC\/MEK\/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL","volume":"19","author":"Cho HM","year":"2005","journal-title":"Mol Cells"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1457"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5228"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2483"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412555200"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.00220"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.17.7686"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2005.07.005"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-1738(01)00165-7"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5430.1028"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat1994.1.Supplemment1_S47"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118693"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.16.9052"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.10.031"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3091021"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90115-S"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200208043"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00442.2007"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400234"},{"key":"e_1_2_8_26_1","first-page":"L558","article-title":"MEK1 is required for PDGF\u2010induced ERK activation and DNA synthesis in tracheal myocytes","volume":"272","author":"Karpova AY","year":"1997","journal-title":"Am J Physiol"},{"key":"e_1_2_8_27_1","first-page":"1085","article-title":"Activation of the NF\u2010kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule\u20101 and monocyte chemoattractant protein\u20101","volume":"151","author":"Landry DB","year":"1997","journal-title":"Am J Pathol"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.121.1.163"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-06-0201"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109101200"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(97)80061-0"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.40.28371"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1359"},{"key":"e_1_2_8_34_1","first-page":"1070","article-title":"Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen\u2010coated membranes","volume":"145","author":"Skinner MP","year":"1994","journal-title":"Am J Pathol"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118808"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401658"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1994"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(94)90296-8"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.151415"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00211-7"},{"key":"e_1_2_8_41_1","first-page":"324","article-title":"Relationship between expression of type III collagen and phenotype of vascular smooth muscle cells in neointimal of stented coronary artery","volume":"113","author":"Xiang D","year":"2000","journal-title":"Chin Med J (Engl)"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000234200"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0531-5565(03)00170-0"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2008.00095.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2008.00095.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T21:03:17Z","timestamp":1710104597000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2008.00095.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1476-5381.2008.00095.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00095.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"2009-03-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}